Predictors of Quality of Life Improvement with Escitalopram and Adjunctive Aripiprazole in Patients with Major Depressive Disorder: A CAN-BIND Study Report.
Emma MortonVenkat BhatPeter GiacobbeWendy LouErin E MichalakShane McInerneyTrisha ChakrabartyBenicio N FreyRoumen V MilevDaniel J MüllerSagar V ParikhSusan RotzingerSidney H KennedyRaymond W Lamnull nullPublished in: CNS drugs (2021)
ClinicalTrials.gov identifier: NCT016557.